Insights Into Prostate Cancer 2021
Perspectives of community physicians on the treatment of prostate cancer, recently introduced and upcoming agents
Puerto Rico – March 27, 2021
Faculty Chair
Jorge A. Garcia, MD, FACP
Case Comprehensive Cancer Center, Cleveland, OH
Northeast – November 9, 2021
Faculty Chair
Scott Tagawa, MD, MS, FACP
Weill Cornell Medical Center, New York, NY
Midwest – November 15, 2021
Faculty Chair
Sandy Srinivas, MD
Stanford University, Stanford, CA
Northwest – December 7, 2021
Faculty Chair
Sandy Srinivas, MD
Stanford University, Stanford, CA
Puerto Rico – December 13, 2021
Faculty Chair
Jorge A. Garcia, MD, FACP
Case Comprehensive Cancer Center, Cleveland, OH
REPORT SNAPSHOT
- A virtual, moderated roundtable discussion focusing on the treatment of prostate cancer
- Disease state and data presentations are developed in conjunction with a national or regional oncology expert
- Insights on the following therapies will be obtained: apalutamide, darolutamide, enzalutamide, androgen deprivation therapy, docetaxel, abiraterone and combinations of these drugs
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- Data collection is accomplished through use of audience response system questioning and moderated discussion
- The group of advisors will comprise 10–15 medical oncologists representative of each region
